? EGFR/ALK testing is recommended for lung adenocarcinoma patients for EGFR/ALK-targeted TKI therapy.     ///    ? EGFR /ALK testing is restricted by limited tissue samples and cost pressures.     ///    ? pGGO and TDR are predictive factors for selecting patients for ALK/EGFR testing.. 